Intended for healthcare professionals

Letters Drug prevention of hypertension

Up to a point

BMJ 2009; 338 doi: (Published 29 June 2009) Cite this as: BMJ 2009;338:b2601
  1. Michael Schachter, senior lecturer in clinical pharmacology1
  1. 1Imperial College London, St Mary’s Hospital, London W2 1NY
  1. m.schachter{at}

    This debate parallels that on statins and cholesterol.1 Lowering low density lipoprotein (LDL) cholesterol, like lowering blood pressure, will almost always lower the risk of cardiovascular events, and the relative risk reduction will be similar regardless of starting blood pressure or LDL concentration. But the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription